119 related articles for article (PubMed ID: 11278393)
1. The cell cycle inhibitor p16(INK4A) sensitizes lymphoblastic leukemia cells to apoptosis by physiologic glucocorticoid levels.
Ausserlechner MJ; Obexer P; Wiegers GJ; Hartmann BL; Geley S; Kofler R
J Biol Chem; 2001 Apr; 276(14):10984-9. PubMed ID: 11278393
[TBL] [Abstract][Full Text] [Related]
2. The cell cycle inhibitor p16(INK4A) sensitizes lymphoblastic leukemia cells to apoptosis by physiologic glucocorticoid levels.
Ausserlechner MJ; Obexer P; Wiegers GJ; Hartmann BL; Geley S; Kofler R
J Biol Chem; 2001 Jun; 276(24):10984-9. PubMed ID: 11441822
[TBL] [Abstract][Full Text] [Related]
3. G1 arrest by p16INK4A uncouples growth from cell cycle progression in leukemia cells with deregulated cyclin E and c-Myc expression.
Ausserlechner MJ; Obexer P; Geley S; Kofler R
Leukemia; 2005 Jun; 19(6):1051-7. PubMed ID: 15800668
[TBL] [Abstract][Full Text] [Related]
4. p16INK4A sensitizes human leukemia cells to FAS- and glucocorticoid-induced apoptosis via induction of BBC3/Puma and repression of MCL1 and BCL2.
Obexer P; Hagenbuchner J; Rupp M; Salvador C; Holzner M; Deutsch M; Porto V; Kofler R; Unterkircher T; Ausserlechner MJ
J Biol Chem; 2009 Nov; 284(45):30933-40. PubMed ID: 19737931
[TBL] [Abstract][Full Text] [Related]
5. Human p16gamma, a novel transcriptional variant of p16(INK4A), coexpresses with p16(INK4A) in cancer cells and inhibits cell-cycle progression.
Lin YC; Diccianni MB; Kim Y; Lin HH; Lee CH; Lin RJ; Joo SH; Li J; Chuang TJ; Yang AS; Kuo HH; Tsai MD; Yu AL
Oncogene; 2007 Oct; 26(49):7017-27. PubMed ID: 17486064
[TBL] [Abstract][Full Text] [Related]
6. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
[TBL] [Abstract][Full Text] [Related]
7. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death.
Kim LH; Peh SC; Poppema S
Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421
[TBL] [Abstract][Full Text] [Related]
8. Expression of p16 induces transcriptional downregulation of the RB gene.
Fang X; Jin X; Xu HJ; Liu L; Peng HQ; Hogg D; Roth JA; Yu Y; Xu F; Bast RC; Mills GB
Oncogene; 1998 Jan; 16(1):1-8. PubMed ID: 9467937
[TBL] [Abstract][Full Text] [Related]
9. Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16(INK4A) and p18, in childhood T cell lineage acute lymphoblastic leukemias.
Iolascon A; Faienza MF; Coppola B; della Ragione F; Schettini F; Biondi A
Leukemia; 1996 Feb; 10(2):255-60. PubMed ID: 8637234
[TBL] [Abstract][Full Text] [Related]
10. γ-Tocotrienol prevents cell cycle arrest in aged human fibroblast cells through p16
Zainuddin A; Chua KH; Tan JK; Jaafar F; Makpol S
J Physiol Biochem; 2017 Feb; 73(1):59-65. PubMed ID: 27743340
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of p16(ink4a) inhibits cell proliferation and induces G1 cell cycle arrest in cervical cancer cells.
Zhang CY; Bao W; Wang LH
Int J Mol Med; 2014 Jun; 33(6):1577-85. PubMed ID: 24714974
[TBL] [Abstract][Full Text] [Related]
12. Transgenic expression of the p16(INK4a) cyclin-dependent kinase inhibitor leads to enhanced apoptosis and differentiation arrest of CD4-CD8- immature thymocytes.
Lagresle C; Gardie B; Eyquem S; Fasseu M; Vieville JC; Pla M; Sigaux F; Bories JC
J Immunol; 2002 Mar; 168(5):2325-31. PubMed ID: 11859122
[TBL] [Abstract][Full Text] [Related]
13. p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice.
Shank-Calvo JA; Draheim K; Bhasin M; Kelliher MA
Oncogene; 2006 May; 25(21):3023-31. PubMed ID: 16407836
[TBL] [Abstract][Full Text] [Related]
14. Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia.
Omura-Minamisawa M; Diccianni MB; Batova A; Chang RC; Bridgeman LJ; Yu J; Pullen J; Bowman WP; Yu AL
Clin Cancer Res; 2000 Apr; 6(4):1219-28. PubMed ID: 10778944
[TBL] [Abstract][Full Text] [Related]
15. Forced expression of the cyclin-dependent kinase inhibitor p16(INK4A) in leukemic U-937 cells reveals dissociation between cell cycle and differentiation.
Bergh G; Telleus A; Fritzon A; Kornfält S; Johnson E; Olsson I; Gullberg U
Exp Hematol; 2001 Dec; 29(12):1382-91. PubMed ID: 11750096
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells.
Ausserlechner MJ; Obexer P; Böck G; Geley S; Kofler R
Cell Death Differ; 2004 Feb; 11(2):165-74. PubMed ID: 14576768
[TBL] [Abstract][Full Text] [Related]
17. The role of p16 in the E2F-dependent thymidine kinase regulation.
Hengstschläger M; Hengstschläger-Ottnad E; Pusch O; Wawra E
Oncogene; 1996 Apr; 12(8):1635-43. PubMed ID: 8622883
[TBL] [Abstract][Full Text] [Related]
18. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
19. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
20. Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.
Krämer A; Schultheis B; Bergmann J; Willer A; Hegenbart U; Ho AD; Goldschmidt H; Hehlmann R
Leukemia; 2002 Sep; 16(9):1844-51. PubMed ID: 12200702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]